Author
Norikazu Masuda
Also Known As
Daigo Yamamoto, Hiroji Iwata, Masuda N, Masuda, Norikazu, N Masuda, N. Masuda, Norihito Masuda, Norikazu MASUDA, Norikazu Masuda, Valeria Masiello
693
Publications
29.3K
Citations
64
H-Index
102
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 45 | 123 | 13.3K |
2 | Health Sciences | 20 | 33 | 7.7K |
3 | Nursing | 2 | 2 | 58 |
4 | Biostatistics | 2 | 2 | 36 |
5 | Engineering | 1 | 1 | 105 |
Norikazu Masuda
×
234
Publications
28.4K
Citations
63
H-Index
| Year | Citations | |
|---|---|---|
2017 | 3.1K | |
2017 | 1.8K | |
2016 | 1.8K | |
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Javier Cortés, David W. Cescon, Hope S. Rugo, Chemotherapy Versus PlaceboBreast OncologyOncologyClinical TrialsBreast Cancer | 2020 | 1.7K |
2017 | 1.6K | |
2018 | 1.2K | |
2022 | 968 | |
2019 | 941 | |
2020 | 854 | |
2015 | 757 |
Page 1
Page 1